What is Waymark?
Founded in 2021, Waymark operates at the intersection of healthtech and community-based care. The company specializes in deploying advanced technological frameworks to support healthcare providers in delivering more effective, data-informed patient outcomes. By focusing on the community care segment, Waymark addresses the complex needs of diverse patient populations, positioning itself as a vital intermediary in the modern healthcare ecosystem. Its market position is defined by a commitment to improving care quality while optimizing the administrative and clinical workflows that underpin the broader health sector.
How much funding has Waymark raised?
Waymark has raised a total of $87M across 2 funding rounds:
Series A
$45M
Other Financing Round
$42M
Series A (2022): $45M with participation from New Enterprise Associates and Andreessen Horowitz
Other Financing Round (2023): $42M led by New Enterprise Associates, Lux Capital, and Andreessen Horowitz
Key Investors in Waymark
New Enterprise Associates
Established in 1977 and headquartered in Menlo Park, California, New Enterprise Associates is a venture capital firm focused on helping entrepreneurs build businesses.
Lux Capital
Lux Capital is a New York based venture capital firm that raises dedicated funds to invest in early-stage and growth-stage companies at the intersection of science and technology.
Andreessen Horowitz
Founded in 2009, Andreessen Horowitz is a private American venture capital firm that invests in both early-stage start-ups and established growth companies.
What's next for Waymark?
With the recent influx of capital, Waymark is expected to prioritize the expansion of its technological platform and the deepening of its provider partnerships. The strategic roadmap likely includes scaling its data analytics capabilities to better serve community health organizations and potentially entering new geographic markets. As the company matures, the focus will shift toward long-term sustainability and the integration of its services into larger enterprise health networks. Investors are closely monitoring how Waymark will utilize this liquidity to solidify its competitive advantage in a crowded healthtech market, particularly as it seeks to bridge the gap between clinical innovation and practical, community-level application.
See full Waymark company page
